Cargando…

Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system

OBJECTIVE: Cardiovascular diseases are the leading cause of death in Brazil, imposing substantial economic burden on the health care system. Familial hypercholesterolemia (FH) is known to greatly increase the risk of premature coronary artery disease (CAD). This study aimed to estimate the economic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bahia, Luciana R., Rosa, Roger S., Santos, Raul D., Araujo, Denizar V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118785/ https://www.ncbi.nlm.nih.gov/pubmed/29791657 http://dx.doi.org/10.20945/2359-3997000000030

Ejemplares similares

Costs of cancer attributable to excess body weight in the Brazilian public health system in 2018
por: Corrêa Ferreira da Silva, Ronaldo, et al.
Publicado: (2021)

The costs of overweight and obesity-related diseases in the Brazilian public health system: cross-sectional study
por: Bahia, Luciana, et al.
Publicado: (2012)

Disease and Economic Burden of Hospitalizations Attributable to Diabetes Mellitus and Its Complications: A Nationwide Study in Brazil
por: Quarti Machado Rosa, Michelle, et al.
Publicado: (2018)

Cost of diseases related to alcohol consumption in the Brazilian Unified Health System
por: Coutinho, Evandro Silva Freire, et al.
Publicado: (2016)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022)

The Economic Burden of HIV/AIDS and Myocardial Infarction Treatment in Brazil
por: Araújo, Denizar Vianna, et al.
Publicado: (2013)

Economic burden of diabetes in Brazil in 2014
por: Bahia, Luciana Ribeiro, et al.
Publicado: (2019)

Estimated cost of asthma in outpatient treatment: a real-world study
por: Costa, Eduardo, et al.
Publicado: (2018)

New Trends and Therapies for Familial Hypercholesterolemia
por: Alnouri, Fahad, et al.
Publicado: (2022)

The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia
por: Santos, Paulo C.J.L., et al.
Publicado: (2014)

Past, Present, and Future of Familial Hypercholesterolemia Management
por: Rocha, Viviane Z., et al.
Publicado: (2021)

Acute Coronary Syndrome Treatment Costs from the Perspective of the Supplementary Health System
por: Teich, Vanessa, et al.
Publicado: (2015)

Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied
por: Ungar, Leo, et al.
Publicado: (2018)

Premature Coronary Artery Disease due to Homozygous Familial Hypercholesterolemia in a 12-Year-Old Girl
por: Ekici, Filiz, et al.
Publicado: (2018)

Familial hypercholesterolemia and vulnerability of coronary plaque in patients with coronary artery disease
por: Katamine, Masahiro, et al.
Publicado: (2021)

Association of Peripheral Arterial and Cardiovascular Diseases in Familial Hypercholesterolemia
por: Pereira, Carolina, et al.
Publicado: (2014)

Attributable mortality due to nosocomial sepsis in Brazilian hospitals: a case–control study
por: Zampieri, Fernando G., et al.
Publicado: (2023)

Economic burden of colorectal and breast cancers attributable to lack of physical activity in Brazil
por: Rezende, Leandro F. M., et al.
Publicado: (2021)

Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study
por: Pérez de Isla, Leopoldo, et al.
Publicado: (2023)

On the use of the “Population Attributable Fraction”: application in cost estimation
por: Martini, Alberto
Publicado: (2021)

Cost estimate of hospital stays for premature newborns of adolescent mothers in a Brazilian public hospital
por: Mwamakamba, Lutufyo Witson, et al.
Publicado: (2014)

Low-Cost High-Throughput Genotyping for Diagnosing Familial Hypercholesterolemia
por: Ibrahim, Shirin, et al.
Publicado: (2023)

Familial Hypercholesterolemia Genetic Variations and Long-Term Cardiovascular Outcomes in Patients with Hypercholesterolemia Who Underwent Coronary Angiography
por: Lee, Wen-Jane, et al.
Publicado: (2021)

Primary coronary artery pseudoaneurysm in a patient with familial hypercholesterolemia
por: Fujiyoshi, Toshiki, et al.
Publicado: (2019)

Healthy Lifestyles and Cardiovascular Disease in Familial Hypercholesterolemia: Can We Change the Impact of Genes?
por: Santos, Raul D.
Publicado: (2023)

Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease
por: Tada, Hayato, et al.
Publicado: (2018)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Annual Direct Medical Costs of Diabetic Foot Disease in Brazil: A Cost of Illness Study
por: Toscano, Cristiana M., et al.
Publicado: (2018)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

EE240 Estimating the COVID-19 Cost-of-Illness Associated with Comorbidities in a Brazilian Public Hospital
por: Oliveira, LA, et al.
Publicado: (2022)

Advancing Prediction of Pathogenicity of Familial Hypercholesterolemia LDL Receptor Commonest Variants With Machine Learning Models
por: Santos, Raul D.
Publicado: (2021)

Sailing the Uncharted Waters of Familial Hypercholesterolemia LDL Receptor Genetic-Related Variants: Land in Sight?
por: Santos, Raul D.
Publicado: (2023)

Estimating Premature Mortality Cost of Cancers Attributable to Obesity in Indonesia
por: Riantoro, Bagus Dwiky, et al.
Publicado: (2019)

Mendelian randomization: estimation of inpatient hospital costs attributable to obesity
por: Dick, Katherine, et al.
Publicado: (2021)

Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition
por: Vuorio, Alpo, et al.
Publicado: (2021)

Redux valvular surgery with coronary artery bypass graft in familial hypercholesterolemia
por: Jalel, Ziadi, et al.
Publicado: (2014)

The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (I): - Contribution to the Elucidation of the Pathophysiology of Human Hypercholesterolemia and Coronary Heart Disease -
por: Shiomi, Masashi
Publicado: (2020)

Mortality and years of life lost due to breast cancer attributable to physical inactivity in the Brazilian female population (1990–2015)
por: Silva, Diego Augusto Santos, et al.
Publicado: (2018)

Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System
por: Goncalves, Gabriela Maria Reis, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fhpekmi9guv05s40afaqi1jud9